Luis Borges

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luis Borges:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Century Therapeutics, Inc. Chief Scientific Officer Common Stock 257K $382K $1.49 03 Apr 2023 Direct
Metagenomi, Inc. Chief Scientific Officer Common Stock 69.3K $200K $2.88 01 Apr 2024 Direct
Metagenomi, Inc. Chief Scientific Officer Stock Option (Right to Buy) 291K 01 Apr 2024 Direct
Century Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 0 03 Apr 2023 Direct

Insider Reports Filed by Luis Borges

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGX Metagenomi, Inc. 01 Apr 2024 2 $0 4 Chief Scientific Officer 03 Apr 2024, 20:59
MGX Metagenomi Technologies, LLC 08 Feb 2024 0 $0 3 Chief Scientific Officer 08 Feb 2024, 19:25
IPSC Century Therapeutics, Inc. 03 Apr 2023 2 $7.68K 4 Chief Scientific Officer 05 Apr 2023, 16:27
IPSC Century Therapeutics, Inc. 21 Mar 2023 9 -$179K 4 Chief Scientific Officer 23 Mar 2023, 19:31
IPSC Century Therapeutics, Inc. 02 Feb 2023 4 $0 4 Chief Scientific Officer 06 Feb 2023, 17:50
IPSC Century Therapeutics, Inc. 25 Jan 2022 1 $0 4 Chief Scientific Officer 27 Jan 2022, 15:50
IPSC Century Therapeutics, Inc. 17 Jun 2021 0 $0 3 Chief Scientific Officer 17 Jun 2021, 17:01